Corcept Therapeutics Incorporated.
(NASDAQ : CORT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.14%19.232.0%$603.27m
SHPGShire PLC Sponsored ADR
1.06%172.220.4%$144.06m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.13%144.946.8%$133.30m
PRGOPerrigo Co. Plc
1.75%71.396.8%$92.35m
JAZZJazz Pharmaceuticals Plc
-1.23%156.872.2%$64.32m
ENDPEndo International Plc
0.80%17.658.9%$59.47m
MNKMallinckrodt Plc
0.30%27.2421.1%$57.97m
SAGESAGE Therapeutics, Inc.
-2.62%121.569.6%$46.74m
ICPTIntercept Pharmaceuticals, Inc.
-2.29%101.3618.7%$46.55m
UTHRUnited Therapeutics Corporation
0.40%123.6114.4%$35.05m
CTLTCatalent Inc
0.05%41.492.4%$32.39m
ICLRICON Plc
-0.70%143.914.1%$31.58m
PCRXPacira Pharmaceuticals, Inc.
2.10%45.0710.6%$25.60m
AERIAerie Pharmaceuticals, Inc.
0.78%55.806.9%$25.41m
MDCOMedicines Company
1.11%26.5221.8%$25.09m

Company Profile

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.